Comprehensive Agenda Announced for ASPC's 2025 Congress on CVD Prevention
The American Society for Preventive Cardiology (ASPC) has detailed an extensive program of events for its annual Congress focused on the prevention of cardiovascular diseases (CVD), scheduled for August 1-3, 2025, at the Omni Hotel at the Seaport in Boston, Massachusetts. This year's agenda promises a mix of educational sessions, expert presentations, and collaborative discussions aimed at advancing the science and practice of preventive cardiology.
A notable feature this year is the introduction of the ASPC Cardiovascular Disease Prevention Training Academy, a focused pre-conference course aimed at clinicians in training. This one-day program is designed to provide comprehensive insights into the field of preventive cardiology, ensuring that participants are well-versed in evidence-based practices. Applications were invited earlier this year, and those selected will not only benefit from the course but will also participate in the Congress subsequently. ASPC President, Dr. Michael Shapiro, emphasized the importance of this initiative, stating that it plays a vital role in nurturing the next generation of preventive cardiologists. This initiative underscores ASPC’s commitment to enhancing the future of preventive healthcare through education and mentorship.
The main agenda for the ASPC 2025 Scientific Sessions promises a rich diversity of topics with contributions from leading international experts in the field. Key honors during the congress will be presented to notable figures for their contributions to CVD prevention. The Honorary Fellow Award will be awarded to Dr. Helen Hobbs, a respected Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center. In addition, the Nanette Wenger Award will honor Dr. Harmony Reynolds from NYU Grossman School of Medicine, while Dr. Roger Blumenthal will receive the Joseph Stokes III, MD Pioneer in Prevention Award.
The congress will kick off with an opening session on August 1, where these awards will be presented in a ceremony that sets the tone for the event. Attendees can look forward to session discussions that include the latest insights into lipoprotein management, facilitated by a collaboration between ASPC and the European Atherosclerosis Society (EAS). This partnership showcases the increasing need for global collaboration in addressing cardiovascular health challenges.
The agenda will also feature an exciting lineup of debates addressing pressing questions in the realm of cardiovascular health, scheduled for the first two days of the congress. Topics include contentious issues such as whether the systolic blood pressure target should be under 120 mmHg or under 130 mmHg, and if medications like colchicine should be recommended for secondary prevention of coronary disease. These debates will not only engage participants but also stimulate critical discussions among experts in the field.
In addition to debates, the congress will feature over 200 abstract presentations and poster sessions, facilitating knowledge exchange and allowing researchers and clinicians alike to present their findings. The event will also include 'Expert Theaters', where industry leaders will present relevant topics, and even morning activities such as sunrise yoga to promote well-being among attendees.
This year's Congress is poised to be a unique gathering that not only highlights cutting-edge research and advancements in preventive cardiology but also fosters networking opportunities among clinicians, researchers, and industry professionals. Detailed information regarding the congress agenda is available at www.aspconline.org/2025Congress. The ASPC continues to adhere to its mission of promoting cardiovascular health by providing high-quality, evidence-based educational resources for practitioners and patients alike, making this event a critical venue for learning and collaboration in cardiovascular disease prevention.
A notable feature this year is the introduction of the ASPC Cardiovascular Disease Prevention Training Academy, a focused pre-conference course aimed at clinicians in training. This one-day program is designed to provide comprehensive insights into the field of preventive cardiology, ensuring that participants are well-versed in evidence-based practices. Applications were invited earlier this year, and those selected will not only benefit from the course but will also participate in the Congress subsequently. ASPC President, Dr. Michael Shapiro, emphasized the importance of this initiative, stating that it plays a vital role in nurturing the next generation of preventive cardiologists. This initiative underscores ASPC’s commitment to enhancing the future of preventive healthcare through education and mentorship.
The main agenda for the ASPC 2025 Scientific Sessions promises a rich diversity of topics with contributions from leading international experts in the field. Key honors during the congress will be presented to notable figures for their contributions to CVD prevention. The Honorary Fellow Award will be awarded to Dr. Helen Hobbs, a respected Professor of Internal Medicine and Molecular Genetics at the University of Texas Southwestern Medical Center. In addition, the Nanette Wenger Award will honor Dr. Harmony Reynolds from NYU Grossman School of Medicine, while Dr. Roger Blumenthal will receive the Joseph Stokes III, MD Pioneer in Prevention Award.
The congress will kick off with an opening session on August 1, where these awards will be presented in a ceremony that sets the tone for the event. Attendees can look forward to session discussions that include the latest insights into lipoprotein management, facilitated by a collaboration between ASPC and the European Atherosclerosis Society (EAS). This partnership showcases the increasing need for global collaboration in addressing cardiovascular health challenges.
The agenda will also feature an exciting lineup of debates addressing pressing questions in the realm of cardiovascular health, scheduled for the first two days of the congress. Topics include contentious issues such as whether the systolic blood pressure target should be under 120 mmHg or under 130 mmHg, and if medications like colchicine should be recommended for secondary prevention of coronary disease. These debates will not only engage participants but also stimulate critical discussions among experts in the field.
In addition to debates, the congress will feature over 200 abstract presentations and poster sessions, facilitating knowledge exchange and allowing researchers and clinicians alike to present their findings. The event will also include 'Expert Theaters', where industry leaders will present relevant topics, and even morning activities such as sunrise yoga to promote well-being among attendees.
This year's Congress is poised to be a unique gathering that not only highlights cutting-edge research and advancements in preventive cardiology but also fosters networking opportunities among clinicians, researchers, and industry professionals. Detailed information regarding the congress agenda is available at www.aspconline.org/2025Congress. The ASPC continues to adhere to its mission of promoting cardiovascular health by providing high-quality, evidence-based educational resources for practitioners and patients alike, making this event a critical venue for learning and collaboration in cardiovascular disease prevention.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.